Published in J Virol on November 01, 2006
Genomic fossils calibrate the long-term evolution of hepadnaviruses. PLoS Biol (2010) 1.57
Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J Mol Evol (2007) 1.25
Genomic analysis of hepatitis B virus reveals antigen state and genotype as sources of evolutionary rate variation. Viruses (2011) 1.09
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. PLoS One (2012) 1.06
Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J Virol (2010) 1.00
Universal Primers for Detection and Sequencing of Hepatitis B Virus Genomes across Genotypes A to G. J Clin Microbiol (2015) 0.98
HBVRegDB: annotation, comparison, detection and visualization of regulatory elements in hepatitis B virus sequences. Virol J (2007) 0.97
Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. J Viral Hepat (2009) 0.96
Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS One (2012) 0.93
The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses. Nat Commun (2013) 0.93
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. J Virol (2011) 0.92
Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan. J Clin Microbiol (2011) 0.92
Endogenous hepadnaviruses, bornaviruses and circoviruses in snakes. Proc Biol Sci (2014) 0.89
Evolution of foamy viruses: the most ancient of all retroviruses. Viruses (2013) 0.89
Bayesian inference of the evolution of HBV/E. PLoS One (2013) 0.88
Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C. Viruses (2010) 0.87
Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylase. PLoS One (2011) 0.87
The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Rev Med Virol (2016) 0.86
New insights into the evolutionary rate of hepatitis B virus at different biological scales. J Virol (2015) 0.85
Number of mutations within CTL-defined epitopes of the hepatitis B Virus (HBV) core region is associated with HBV disease progression. J Med Virol (2011) 0.85
Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity. J Clin Microbiol (2013) 0.84
Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach. World J Gastroenterol (2013) 0.84
Virus-related liver cirrhosis: molecular basis and therapeutic options. World J Gastroenterol (2014) 0.83
Recent population expansions of hepatitis B virus in the United States. J Virol (2014) 0.82
BAsE-Seq: a method for obtaining long viral haplotypes from short sequence reads. Genome Biol (2014) 0.82
Hepatitis B virus genotypes and genome characteristics in China. World J Gastroenterol (2015) 0.80
Investigating selection on viruses: a statistical alignment approach. BMC Bioinformatics (2008) 0.79
A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier. Virol J (2010) 0.77
Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression. PLoS One (2013) 0.77
Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors. Antiviral Res (2016) 0.76
Phylogeography and evolutionary history of hepatitis B virus genotype F in Brazil. Virol J (2013) 0.76
Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission. PLoS One (2016) 0.75
Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs. PLoS One (2016) 0.75
Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients. PLoS One (2016) 0.75
Clinical implications of evolutionary patterns of homologous, full-length hepatitis B virus quasispecies in different hosts after perinatal infection. J Clin Microbiol (2014) 0.75
Absence of Hepatitis B Resistance Mutants before Introduction of Oral Antiviral Therapy. ISRN Hepatol (2013) 0.75
Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China. Clin Exp Med (2014) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
MEGA2: molecular evolutionary genetics analysis software. Bioinformatics (2001) 38.50
Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol (1986) 36.06
PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res (1996) 6.04
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
A web-based genotyping resource for viral sequences. Nucleic Acids Res (2004) 2.68
Genetic variability in hepatitis B viruses. J Gen Virol (2002) 2.45
Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues. Proc Natl Acad Sci U S A (1985) 2.25
Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol (2005) 2.24
Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol (2006) 2.21
A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A (2002) 2.02
Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med (1987) 1.93
The origin and evolution of hepatitis viruses in humans. J Gen Virol (2001) 1.75
Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods (1998) 1.73
A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol (2002) 1.57
Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol (1997) 1.49
Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol (1994) 1.36
Long-term mutation rates in the hepatitis B virus genome. J Gen Virol (2000) 1.33
Molecular virology and the development of resistant mutants: implications for therapy. Semin Liver Dis (2005) 1.31
High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology (1996) 1.25
Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med (1997) 1.23
Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J Med Virol (1982) 1.17
Hepatitis B viral resistance: mechanisms and diagnosis. J Hepatol (2003) 1.07
Genetic variation in HBV infection: genotypes and mutants. J Clin Virol (2006) 1.05
Molecular evolution of hepatitis viruses. Intervirology (1999) 1.04
Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay. J Clin Microbiol (2002) 0.99
HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability. J Infect Dis (2006) 0.98
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral Res (2003) 0.90
Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology (2004) 0.89
High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol (1997) 0.85
Hepatitis B virus: pathogenesis, viral intermediates, and viral replication. Clin Liver Dis (2004) 0.85
[Vertical transmission of hepatitis B from a maternal HBeAg-negative and antiHBe-positive carrier]. An Esp Pediatr (1985) 0.78
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet (2009) 14.16
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology (2003) 7.35
Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology (2010) 4.58
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol (2008) 4.55
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology (2007) 3.08
Hepatitis C pharmacogenetics: state of the art in 2010. Hepatology (2011) 2.99
Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology (2002) 2.85
Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol (2005) 2.63
Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57
Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem (2004) 2.32
A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol (2009) 2.20
Classifying hepatitis B virus genotypes. Intervirology (2003) 2.20
Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center. Am J Gastroenterol (2002) 2.10
What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? J Hepatol (2008) 2.05
A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A (2002) 2.02
Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology (2003) 2.02
Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology (2012) 2.00
Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma. Int J Hematol (2009) 2.00
Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial. Ann Intern Med (2007) 1.92
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol (2002) 1.82
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. J Hepatol (2010) 1.80
The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion. Am J Gastroenterol (2009) 1.72
A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol (2005) 1.71
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology (2006) 1.65
Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology (2006) 1.60
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Rapid detection of hepatitis B virus mutations using real-time PCR and melting curve analysis. Hepatology (2002) 1.58
Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II. Prev Med (2012) 1.56
A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. J Gastroenterol (2010) 1.53
Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J Clin Microbiol (2005) 1.53
Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res (2010) 1.53
Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol (2008) 1.53
C sign for diagnosis of talocalcaneal coalition. Radiology (2003) 1.53
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int (2014) 1.49
Visceral Abdominal Obesity Measured by Computed Tomography is Associated With Increased Risk of Colonic Diverticulosis. J Clin Gastroenterol (2015) 1.47
Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype. J Clin Microbiol (2003) 1.45
High-dose barium impaction therapy for the recurrence of colonic diverticular bleeding: a randomized controlled trial. Ann Surg (2015) 1.45
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One (2012) 1.44
The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan. Am J Gastroenterol (2003) 1.44
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection. J Gastroenterol (2004) 1.43
Anatomy of the ulnar artery as it relates to the transverse carpal ligament. J Hand Surg Am (2002) 1.43
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology (2006) 1.43
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res (2007) 1.40
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol (2006) 1.40
Effectiveness of Bone Marrow Stromal Cell Sheets in Maintaining Random-Pattern Skin Flaps in an Experimental Animal Model. Plast Reconstr Surg (2015) 1.38
Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F). J Virol (2002) 1.36
An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int (2011) 1.36
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
Cell sheet transplantation of cultured mesenchymal stem cells enhances bone formation in a rat nonunion model. Bone (2009) 1.32
Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt. J Med Virol (2003) 1.31
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet (2011) 1.31
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology (2006) 1.31
A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep (2013) 1.27
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B. J Clin Microbiol (2011) 1.25
Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Rep (2010) 1.24
Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J Clin Microbiol (2007) 1.23
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat (2014) 1.23
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis (2004) 1.22
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol (2003) 1.21
Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol (2006) 1.20
Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol (2004) 1.19
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology (2014) 1.19
Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J Gen Virol (2006) 1.18
Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J Korean Med Sci (2005) 1.18
Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol (2006) 1.16
The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J Virol (2007) 1.16
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. PLoS One (2012) 1.15
Pyogenic granuloma of the stomach successfully treated by endoscopic resection after transarterial embolization of the feeding artery. J Gastroenterol (2005) 1.15
Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2. J Clin Microbiol (2007) 1.14